ArticleArthritis care & research2018

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

Casper Webers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.